Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.
Press releases published on August 8, 2025
Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance Commitment Through Key Proposals
GlobeNewswire
·
August 8, 2025
Since Founder, YT Jia was appointed as the Co-CEO in April, FF has achieved a major leap in both operational and capital fundamentals, market confidence has rebounded significantly and the Company’s market capitalization has increased by nearly 300%. …
Alamos Gold Announces Filing of Base Shelf Prospectus
GlobeNewswire
·
August 8, 2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) announced that it has filed a base shelf prospectus dated August 8, 2025 (the “Base Shelf Prospectus”) with the Ontario Securities Commission, …
Paul Mueller Company Announces Quarterly Cash Dividend
GlobeNewswire
·
August 8, 2025
SPRINGFIELD, Mo., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 30 cents ($0.30) per share on its outstanding common stock. The action was taken on August 8, …
#1 Best Selling Author, Robert J. Smith, MFA Unveils New Groundbreaking Business Guide
GlobeNewswire
·
August 8, 2025
A Media Snippet accompanying this announcement is available by clicking on this link. WINTER GARDEN, Fla., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Smith Profits is thrilled to announce the release of Robert J. Smith, MFA's latest book: "Everything you always …
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
GlobeNewswire
·
August 8, 2025
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through engineered CD55 membrane expression; IND …
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
GlobeNewswire
·
August 8, 2025
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched Mont-Saint-Guibert, Belgium – August 8, 2025, 10:10pm CET / 4:10pm ET – …
Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil
GlobeNewswire
·
August 8, 2025
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil Lancement Officiel de la Commercialisation aux États-Unis Mont-Saint-Guibert, …
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 8, 2025
Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision and Ophthalmology Annual Meeting and …
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
August 8, 2025
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the first PROteolysis TArgeting Chimera ( …
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 8, 2025
BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options …
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 8, 2025
FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment Significant regulatory and pipeline advancements achieved …
Commerce to Present at Upcoming Investor Conference
GlobeNewswire
·
August 8, 2025
AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …
Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
GlobeNewswire
·
August 8, 2025
ATHENS, Greece, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) (the “Corporation” or “CCEC”) has called an annual meeting of shareholders to be held at the Corporation’s headquarters in Greece …
Phunware Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 8, 2025
Delivers Strong First Half with Key Product Milestones and Customer Momentum Strong Liquidity Powering New Technology Improvements, AI Integration and Corporate Initiatives AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the …
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hyperion Defi, Inc. (NASDAQ: HYPD), the first U.S. public company to build a strategic treasury around the HYPE token and a pioneer in integrating decentralized finance with traditional corporate treasury …
Amwell makes grant to new employees under inducement plan
GlobeNewswire
·
August 8, 2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new …
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
GlobeNewswire
·
August 8, 2025
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone outperformed a …
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
GlobeNewswire
·
August 8, 2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended …
IPG Chicago Facility Achieves TRUE Gold Zero Waste Certification
GlobeNewswire
·
August 8, 2025
SARASOTA, Fla., Aug. 08, 2025 (GLOBE NEWSWIRE) -- IPG (“the Company”), a global provider of packaging and protective solutions, announced that its manufacturing facility in Chicago, IL, has been awarded GOLD certification under the TRUE (Total Resource Use …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 8, 2025
WESTLAKE VILLAGE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …